KENNEDY CAPITAL SMALL CAP VALUE FUND HALO Holdings History
KENNEDY CAPITAL SMALL CAP VALUE FUND's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, Investment Managers Series Trust II held 5,410.00 shares of Halozyme Therapeutics Inc(HALO), totaling $345,210.00. This investment constitutes 1.61% of their stock portfolio, and Investment Managers Series Trust II now holds 0% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2022Q2. And since then KENNEDY CAPITAL SMALL CAP VALUE FUND has made 9 purchases of HALO, at an average price of $42.79, for a total of 6,312.00 shares. In addition, there have been 1 sales at an average price of $57.33 for 902.00 shares. Based on historical transaction data and HALO's current price of $58.01, KENNEDY CAPITAL SMALL CAP VALUE FUND's estimated gain on his HALO holdings is $95,443.95, reflecting a 35.34% gain to date.
KENNEDY CAPITAL SMALL CAP VALUE FUND HALO ($58.01) Holding Chart
KENNEDY CAPITAL SMALL CAP VALUE FUND HALO ($58.01) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
